Pfizer Inc (PFE)
Debt-to-assets ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | 61,538,000 | 32,884,000 | 36,195,000 | 37,133,000 | 35,955,000 |
| Total assets | US$ in thousands | 227,000,000 | 197,000,000 | 181,000,000 | 154,229,000 | 167,594,000 |
| Debt-to-assets ratio | 0.27 | 0.17 | 0.20 | 0.24 | 0.21 |
December 31, 2023 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $61,538,000K ÷ $227,000,000K
= 0.27
The debt-to-assets ratio for Pfizer Inc. has fluctuated over the past five years, ranging from 0.18 to 0.32. In 2023, the ratio increased to 0.32 from 0.18 in the previous year, indicating that a higher proportion of Pfizer's assets are financed through debt. This suggests that Pfizer may have taken on more debt relative to its assets in the most recent year. Despite the increase, the debt-to-assets ratio remains below 1, indicating that Pfizer's assets still predominantly finance its operations rather than debt. It is important for investors and stakeholders to monitor this ratio to assess Pfizer's leverage and financial risk over time.
Peer comparison
Dec 31, 2023